Study of Inhaled Iloprost for the Treatment of Pulmonary Hypertension After Repair of Congenital Heart Disease
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to assess the efficacy and appropriate dose of iloprost for
inhalation in the treatment of postoperative pulmonary hypertension in children with
congenital heart defects.